
Project Details
Start Date
November 2023
Status
Open to Recruitment
Principal Investigator
Dr Gordon Duncan
NDN Study Lead
Jessica Crossan
Main Research Site
Western General Hospital
This clinical trial looks to see if the medication ondansetron can help treat hallucinations associated with Parkinson’s disease.
What Happens In This Study?
You will either be given a medicine called ondansetron or a placebo (a dummy pill that looks like the medicine but has no active ingredients). Neither you, nor the research team, will know which group you are in.
Can I Join This Study?
To take part in this medical trial, you must meet these 6 requirements:
- Your Diagnosis: A doctor must have confirmed that you have Parkinson’s disease OR Dementia with Lewy Bodies.
- Your Age: You are over 18 years old.
- Your Symptoms: You must be experiencing visual hallucinations due to your Parkinson’s disease OR Dementia with Lewy Bodies. These must have been happening at least once a week for the past month.
- Your Current Medicine: You must have been taking the same Parkinson’s medication for at least the last 1 month without making any big changes to it.
- Your Time: You must do your best to attend all your study visits, and follow the rules of the study until it ends.
- Taking the Medicine: You must be willing and able to swallow the trial medication.
Study Length: 24 weeks (6 months)
Number of appointments: 3 visits, plus check in phone calls
More information on the trial can be on the UCL website.
To find out more about this research study, please contact:
loth.sdcrn@nhs.scot
0131 537 3804
















